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Expression of CD27 on Murine Hematopoietic Stem
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1998) and transient expression of CD34 by mouse HSC
during expansion (Sato et al., 1999). Despite many ef-
forts to isolate a pure HSC population based on patterns
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of antigen expression in combination with differences*Departments of Oncological Sciences, Human
in cell size, density, and the uptake of fluorescent probesGenetics, and Pathology and
such as rhodamine-123 (Rho), the resulting cell popula-Department of Medicine, Division of Hematology
tions remain heterogeneous (Jones et al., 1996; JordanUniversity of Utah
et al., 1996; Uchida et al., 1996; Goodell et al., 1997;Salt Lake City, Utah 84132
Gothot et al., 1998). In vitro systems that can be manipu-²Department of Molecular Biology
lated to alter the balance between the decisions of self-Princeton University
renewal versus lineage commitment have only recentlyPrinceton, New Jersey 08544
been developed (Nutt et al., 1999). However, the hetero-
geneity of the HSC compartment has made determina-
tion of the molecular regulators of stem cell fate choicesSummary
almost entirely obscure.
An alternative avenue to shed light on the molecularHematopoietic stem cells (HSC) are defined by self-
components involved in stem cell regulation is providedrenewal and multilineage differentiation potentials. In
by recent technologies that facilitate global gene ex-order to uncover the genetic program of HSC, we uti-
pression comparisons between well-defined cell popu-lized high-density arrays to compare gene expression
lations. Based on numerous precedents in other devel-in highly purified mouse HSC and their mature prog-
opmental systems, we reasoned that stem cell fateeny. One molecule specifically expressed in immature
decisions will be mediated, at least in part, by panelscells is CD27, a member of the TNF receptor family
of gene products expressed uniquely or predominantlypreviously shown to play roles in lymphoid prolifera-
by these cells. As a first approach to identify the genetion, differentiation, and apoptosis. We show here that
expression profile characteristic of primitive but not ma-the CD27 protein is expressed by about 90% of cells
ture mouse hematopoietic cells, we have utilized com-in a purified HSC population. Interestingly, the CD27pos
mercially available high-density nylon membrane arrayscells are enriched for cells with short-term hematopoi-
to interogate the genes differentially expressed by primi-etic activities (colony forming potential in vivo and in
tive HSC in comparison to mature bone marrow cells.vitro), while the minority CD27neg population is more
effective in clonal long-term transplantation.
Results and Discussion
Introduction
The commercial array utilized in these studies (see Ex-
perimental Procedures) contained 18,273 largely nonre-
The rare population of hematopoietic stem cells (HSC)
dundant cDNAs corresponding to known murine gene
in adult bone marrow plays a key role in the life-long products or expressed sequence tags (ESTs). By current
production of steady state populations encompassing estimates this represents approximately 20%±25% of
all hematopoietic cell lineages. A cardinal property of the murine genome. Using optimized PCR-based meth-
HSC is the ability to properly balance self-renewal ver- ods, we synthesized full-length cDNA populations repre-
sus commitment decisions. For clinical transplantation senting Thy1.1lowSca-1posc-kitposLinnegRholow HSC (Rholow),
and for experimental analysis of this unique biological Thy1.1lowSca-1posc-kitposLinnegRhohigh committed progeni-
ability, HSC are often identified and isolated by surface tors (Rhohigh), and fully mature Sca-1negc-kitnegLinpos cells
antigen expression. HSC are known to lack the expres- (Linpos) (Spangrude and Johnson, 1990; Nibley and Span-
sion of a large number of proteins that define myeloid, grude, 1998). In order to overcome the sensitivity barri-
lymphoid, and erythroid lineage cells (Linneg). In contrast, ers inherent in membrane hybridizations, we reduced
the list of antigens that are known to be expressed by the complexities of the cDNA populations by performing
HSC is comparably short. Mouse HSC express major bidirectional subtractive hybridizations according to
histocompatibility complex class I antigens, the c-kit modified standard techniques (Diatchenko et al., 1996).
tyrosine kinase receptor protein, and in some mouse These subtracted cDNA pools, comprising the Rholow
strains, the Thy-1 and Sca-1 antigens (Spangrude et al., HSC population depleted of sequences present in the
1988; Ogawa et al., 1991). There is also evidence that mature Linpos population and the converse cDNA pool,
the CD34 antigen is expressed on murine and human define broad profiles of genes specifically expressed in
HSC (Krause et al., 1994; Morel et al., 1996), although the immature or in the fully differentiated compartments
recent data suggest similar stem cell potential in the of the hematopoietic hierarchy. Duplicate membrane
CD34neg subsets from both species (Osawa et al., 1996; arrays were hybridized with each probe, followed by
Goodell et al., 1997; Bhatia et al., 1998; Morel et al., processing and analysis according to standard meth-
ods. A large number of genes predominantly expressed
in immature cells or in mature cells was identified. A³ To whom correspondence should be addressed (e-mail:
complete description of these results will be reportedilemischka@molbio.princeton.edu [I. L.] and drblood@medschool.
med.utah.edu [G. J. S.]). separately.
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in the hematopoietic hierarchy, we first isolated the Sca-
1posc-kithighLinneg bone marrow HSC population and sub-
sequently analyzed the expression of CD27. As shown
in Figure 2A, about 90% of the purified cells stained
positive for CD27 antigen expression compared to only
about 5% positive cells among total bone marrow cells.
Further analysis indicated that expression of c-kit was
highest on the 10% of Sca-1posc-kithighLinneg cells that
lack CD27 expression (Figure 2B).
In order to address the hematopoietic potential of cell
populations defined by CD27 expression, we utilized
several functional assays. Although HSC function is
most rigorously defined by long-term reconstitution of
transplant recipients, these cells will also read out in a
variety of short-term assays (Li and Johnson, 1992).
Whether the same population of cells is responsible for
short-term colony formation and long-term reconstitu-
tion is controversial (Krause et al., 1994); however, highly
enriched HSC populations have been shown to prolifer-
ate in vitro in response to specific cytokine combinations
(Sitnicka et al., 1996a) and to be highly sensitive to inhibi-
tory cytokines (Sitnicka et al., 1996b).
To determine the colony forming unit-culture (CFU-C)
activity of the two Sca-1posc-kithighLinneg subpopulations
defined by CD27 expression, these cells were isolated
(Figure 2B) and plated into methylcellulose colony
assays. As shown in Figure 3A, the CD27pos population
possessed a high cloning efficiency of approximatelyFigure 1. Differential Expression of the CD27 Gene in the Hemato-
40% when cultured in the presence of multiple recombi-poietic Hierarchy
nant cytokines. In contrast, the cloning efficiency of the(A) Duplicate high-density arrays were hybridized with complex bidi-
rectionally subtracted cDNA probe populations. Left, probe cDNA CD27neg subset was significantly lower (13%, p , 0.001).
is Rholow subtracted with Linpos; right, probe is Linpos subtracted with We next examined the potential of the CD27pos and
Rholow. The spot pair representing the CD27 clone is identified with CD27neg cell populations to form day 13 splenic colonies
an arrow. The ratio of hybridization intensities between the Rholow
(CFU-S). For these experiments, we utilized metabolicand Linpos-specific probes is 643.
staining with the mitochondrial probe Rho in addition(B) Confirmation of differential expression by semiquantitative PCR.
to surface antigen expression to further enrich for HSCA series of PCR cycles were performed on total cDNA preparations
from three different cell populations using primers specific for either (Spangrude et al., 1995). Among the quiescent cells iso-
CD27 or GAPDH. Cycles went from 20 to 35 in 5 cycle increments; lated in the Rholow group, those expressing CD27 formed
thus, each lane represents approximately 32-fold amplification over significantly more CFU-S than CD27neg cells (Figure 3B).
the previous one.
Furthermore, colonies derived from CD27pos cells were
larger in size. The average weight per single colony was
6.9 mg for CD27pos cells compared to 3.4 mg for CD27negOne of the gene products identified in this screen was
cells. In contrast, metabolically active (Rhohigh)Sca-1posCD27, a member of the TNF receptor family. As shown
c-kithighLinneg cells demonstrated no significant differ-in Figure 1, the CD27 position in the array hybridizes
ences between the CD27pos and CD27neg subsets withwith the Rholow-specific probe population but not with
respect to CFU-S frequencies. However, similar to thethe converse Linpos-specific probe population. The ex-
results using Rholow cells, the largest colonies were de-pression of CD27 by both Rholow and Rhohigh hematopoi-
rived from the CD27pos subset.etic stem and progenitor cells but not by mature Linpos
Since reconstitution of lethally irradiated mice is thebone marrow cells was confirmed by RT±PCR analysis
only true measurement of HSC activity, we evaluated(Figure 1B). Expression of CD27 has previously been
the CD27pos and CD27neg cell populations using a com-reported to be strictly limited to T, B, and NK cells (van
petitive long-term repopulation assay. To distinguishLier et al., 1987; Gravestein et al., 1993). Interaction of
donor from recipient, we used C57BL/6 mouse strainsCD27 with its ligand, CD70, is proposed to play a role
that are congenic for different alleles of the Ly-5 antigen.in T cell proliferation, enhanced Ig production by B cells,
Bone marrow cells (Ly-5.1) were sorted for CD27pos andand plasma cell differentiation (Sugita et al., 1991; Good-
CD27neg subpopulations of the RholowSca-1posc-kithighLinnegwin et al., 1993; Agematsu et al., 1997). There is addi-
cells, which have previously been demonstrated to in-tional evidence that CD27, although lacking an intracel-
clude a high frequency of HSC (Spangrude et al., 1995).lular death domain, can induce apoptosis via binding
Lethally irradiated C57BL/6J mice (Ly-5.2) were trans-to SIVA, a proapoptotic protein with a death domain
planted with 10 or 50 sorted congenic cells (Ly-5.1)homology region (Prasad et al., 1997). The potential for
together with 105 syngeneic total bone marrow cells (Ly-a functional significance of CD27 expression by HSC
5.2) to provide radioprotection. In two separate experi-prompted further investigation.
To confirm the differential expression of CD27 protein ments, 8 of 28 mice transplanted with 10 CD27neg cells
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Figure 2. Analysis of CD27 Expression on
Murine Bone Marrow Cell Populations by
FACS and Isolation of Cell Populations for
Functional Analysis
(A) Comparison of CD27 expression by total
bone marrow cells versus a bone marrow
sample after magnetic depletion of cells ex-
pressing maturation antigens (Linneg; top) and
total bone marrow cells versus sorted Sca-
1posc-kithighLinneg cells (bottom).
(B) Linneg cells were stained with phyco-
erythrin (PE)-conjugated Sca-1 and propidium
iodide (PI) and enriched for Sca-1posPIneg cells
using a PE threshold in enrich mode on a
FACS Vantage cell sorter. In a second step,
cells were stained with fluorescein (FITC)-
conjugated CD27 and allophycocyanin (APC)-
conjugated c-kit and sorted for CD27posSca-
1posc-kithigh cells and CD27negSca-1posc-kithigh
cells as indicated.
showed a high percentage (10±78%) of Ly-5.1pos periph- durable grafts were observed only after a delayed kinet-
ics of Ly-5.1pos cell appearance in the peripheral blooderal blood cells derived from this subpopulation (Figures
4A and 4B). In contrast, none of 24 mice transplanted (Figure 4E).
The dose-related differences in the magnitudes andwith 10 CD27pos cells showed long-term engraftment
with Ly-5.1pos cells (Figure 4C). Engraftment kinetics after kinetics of engraftment shown in Figure 4 may represent
a difference in the proliferative potential inherent in thetransplantation of 10 CD27neg cells could be segregated
into two patterns, as previously reported for the total CD27neg and CD27pos subsets. When limiting numbers of
cells were transplanted, the collective contribution ofRholow HSC population (Spangrude et al., 1995). A total
of four recipient animals exhibited rapid engraftment, CD27pos cells to blood production was barely detectable,
while the same input dose of CD27neg cells producedwith Ly-5.1pos cells detected after 3±4 weeks posttrans-
plant (Figure 4B). An additional four animals exhibited vigorous hematopoiesis. An increase of 5-fold in the
transplanted dose of CD27pos cells could, after logarith-a delayed pattern of engraftment, with Ly-5.1pos cells
appearing in large numbers only between 6 and 24 mic expansion, lead to a saturation in blood production
by CD27pos cells in spite of their relative lack of en-weeks posttransplant (Figure 4A). This delay in en-
graftment kinetics is in agreement with previous studies graftment potential at the lower cell dose. Alternatively,
the frequency of self-renewing stem cells may be lowerthat suggested the existence of an HSC population de-
void of early engraftment activity (Jones et al., 1996). in the CD27pos population, so that a dose of 50 cells is
required to transplant at least one self-renewing stemFurthermore, our results also support the conclusion
that highly enriched HSC populations can provide rapid cell whereas a dose of only 10 CD27neg cells is sufficient
to achieve the same effect. There is also the possibilityengraftment upon transplantation (Uchida et al., 1998).
Transplantation of higher cell numbers (50 cells each of that the HSC frequency among CD27pos and CD27neg
cells is equivalent but that the CD27neg cells possess anCD27pos or CD27neg) in the presence of competitive bone
marrow cells resulted in a high level of Ly-5.1pos reconsti- advantage in homing efficiency or survival compared to
the CD27pos subpopulation. Finally, transitional cells thattution in the majority of recipients (4 of 8 animals trans-
planted with CD27pos and 5 of 8 animals transplanted have recently left the CD27neg compartment may be pres-
ent in a low frequency among the CD27pos population,with CD27neg, Figures 4D and 4E). The engraftment ob-
served after transplantation of CD27neg cells again in- and these may be responsible for the engraftment seen
at the higher cell dose.cluded examples of both rapid and delayed engraftment
kinetics, with both types durable to 28 weeks. In con- To determine whether CD27neg cells can support multi-
lineage engraftment, the Ly-5.1pos-derived peripheraltrast, CD27pos grafts resulted in several instances of
rapid engraftment, which subsequently declined, and blood cells in animals transplanted with 10 cells were
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example, purifications of human HSC routinely use the
phenotype CD34posCD38neg, whereas mouse HSC are
contained within both the CD34neg and CD34pos popula-
tions (Sato et al., 1999) and are uniformly CD38pos (Ran-
dall et al., 1996). The significance of these differences
in antigenic profile between HSC of different species is
unknown but may reflect functional redundancies in the
biological activities of the specific proteins.
Ligation of CD27 results in a costimulatory prolifera-
tive response by T lymphocytes (Kobata et al., 1994).
However, we were unable to demonstrate specific costi-
mulatory or inhibitory effects of CD27 ligation on the
short-term in vitro proliferation of HSC in the presence
of several cytokine combinations and immobilized anti-
CD27 antibodies (unpublished data). A more biologically
relevant signal may be delivered after CD27 ligation by
its cognate ligand CD70, perhaps in combination with
other stromal cell-associated molecules. Future experi-
ments will address this possibility.
The expression of CD27 on murine HSC followed by
a loss of expression on early lymphoid progenitor cells
and upregulation on mature lymphocytes is comparable
to the Thy-1.1 antigen, which shows similar differential
expression during mouse hematopoiesis (Kondo et al.,
1997). The functional importance of this kinetic variation
of antigen expression is not known. However, it is not
surprising that a member of the TNF receptor family,
known to regulate proliferation, differentiation, and apo-
ptosis in lymphocytes (Smith et al., 1994), is expressed
on HSC. These biological features are required in the
development from HSC to mature blood cells and are
necessary to maintain steady state equilibrium in the
hematopoietic cell compartment. Therefore, it seems
likely that functional assays will ultimately reveal the
biological importance of CD27 expression on mouse
HSC. In comparison to lymphocytes, CD27 might play aFigure 3. Colony Forming Activity of the CD27pos and CD27neg Sub-
role in cell±cell interaction, regulation of cell proliferationpopulation of the Sca-1posc-kithighLinneg Cells In Vitro and In Vivo
versus apoptosis, and cytokine production. If CD27(A) To determine the colony forming unit-culture (CFU-C) activity,
Sca-1posc-kithighLinneg cells were sorted for CD27pos and CD27neg sub- plays such a regulatory role, other members of the TNF
populations as shown in Figure 2B and plated into methylcellulose receptor family may be expressed on human HSC as
containing recombinant cytokines. On day 9 colonies were counted functional equivalents.
and calculated for cloning efficiency per 100 cells (n 5 4). Equivalent Our present findings demonstrate that CD27 is ex-
results were obtained in two experiments.
pressed on murine hematopoietic stem and progenitor(B) To determine the colony forming unit spleen (CFU-S) potential
cells. The rare population of CD27neg cells among theof the CD27pos and CD27neg subpopulations, cells were sorted as
RholowSca-1posc-kithighLinneg population has higher in vivoshown in Figure 2B. The isolated populations were subsequently
stained with Rho and sorted for the 20% dullest (Rholow) and 20% stem cell activity than the CD27pos cells and supports
brightest (Rhohigh) cells. Lethally irradiated mice were transplanted long-term multilineage engraftment, with both rapid and
with 250 Rholow cells or 100 Rhohigh cells each. On day 13 mice were delayed kinetics. Because the biological activities of this
sacrificed and their spleens were harvested, weighed, fixed, and primitive cell population can be subdivided, our data
analyzed for CFU-S. Colonies were calculated per 250 cells trans-
directly demonstrate its previously suggested heteroge-planted (n 5 12±13). Numbers in parentheses indicate calculated
neity. Our results also underscore the future value ofweight per colony in milligrams. Asterisk, significantly different com-
microarray technology as an avenue for the rapid identi-pared to RholowCD27neg (p , 0.02, unpaired t test).
fication of gene expression patterns within complex,
biologically important, and rare cell populations. In the
present case, an array approach identified a cell surfaceanalyzed by two-color flow cytometry using markers
receptor, which is clearly capable of delivering regula-diagnostic for the major myeloid and lymphoid lineages.
tory signals to HSC. We expect this approach to expres-All mice that showed long-term (28 week) engraftment
sion analysis will yield many additional insights into thewith the transplanted CD27neg HSC contained Ly-5.1pos
regulation of hematopoiesis in both mouse and man.T, B, and myeloid cells (Figure 4F).
In contrast to the results shown here with mouse HSC,
Experimental ProceduresCD27 is not expressed by the vast majority of human
CD34pos cells (Lansdorp et al., 1995; unpublished data). cDNA Synthesis, Subtraction, and Array Analysis
Differences in antigen expression between mouse and The full-length cDNAs were synthesized essentially as described in
the Smart-PCR user manual (Clontech) with minor modifications.human HSC have been reported for other antigens. For
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Figure 4. Competitive Long-Term Repopula-
tion Analysis of the CD27pos and CD27neg Sub-
fractions of the RholowSca-1posc-kithighLinneg
Cell Population
Total bone marrow cells (Ly-5.1) were sorted
for the two cell populations and then injected
into lethally irradiated Ly-5.2 mice at doses
of 10 (A±C) or 50 (D and E) cells in the pres-
ence of 105 normal Ly-5.2 bone marrow cells.
At the indicated times posttransplant, the pe-
ripheral blood of each transplanted animal
was analyzed for the percentage of donor (Ly-
5.1pos) cells. At the 10 cell dose, 8 of 28 ani-
mals transplanted with CD27neg cells showed
durable engraftment (.10% donor cells at 12
and/or 28 weeks posttransplant). Of these, 4
showed significant donor-derived cells only
after 4 weeks (A), while 4 showed engraftment
prior to 4 weeks (B). In contrast, none of 24
animals transplanted with 10 CD27pos cells
engrafted to the 10% donor level at 12 or 28
weeks (C). At the 50 cell dose, 5 of 8 animals
transplanted with CD27neg cells (D) and
4 of 8 animals transplanted with CD27pos cells (E) engrafted above 10% donor cells at week 12 or 28. (F) shows lineage analysis at 28 weeks
posttransplant of the 8 engrafting mice transplanted with 10 CD27neg cells. In all animals, donor-derived cells were detected in T cell, B cell,
and myeloid lineages.
Because the starting amount of material from purified cell popula- 378C for another 20 min to allow Rho efflux. Cells were sorted for
the dullest and brightest 20% of cells in the Rho staining distribution.tions was low (10,000±20,000 cell equivalents), the necessary PCR
cycle numbers were carefully optimized. This was done by a pilot A small sample from CD27pos cells was removed for reanalysis. Due
to low cell numbers, no reanalysis in the CD27neg group was per-amplification reaction from which aliquots were withdrawn at two
cycle increments. These amplified cDNAs were analyzed on tripli- formed.
cate Southern blots, hybridized with GAPDH, b-actin, and CD34.
For each starting cDNA, the cycle number where all three molecules Methylcellulose Assay
were represented by the highest amount of the corresponding full- Cells were plated at a concentration of 100 cells/ml in a methylcellu-
length cDNAs was used in preparative amplifications. Bidirectional lose mixture consisting of 1.2% methylcellulose (1500 cp, Shinetsu,
subtractions were performed according to the PCR-Select user Tokyo, Japan; kindly provided by Dr. Makio Ogawa), 30% fetal calf
manual (Clontech). Subtraction efficiency was verified by hybridiza- serum (GIBCO±BRL), 1% deionized BSA (Sigma Chemical), and 0.1
tion of the subtracted populations to Southern blots containing full- mM 2-mercaptoethanol (Mallinckrodt Chemical). Cells were stimu-
length cDNA representations of the starting cell populations. Dupli- lated with recombinant murine steel factor (STL, 100 ng/ml; kindly
cate Gene Discovery Array (GDA) (Genome Systems) membranes provided by Kirin Pharmaceuticals, Tokyo, Japan), recombinant mu-
were hybridized with bidirectionally 33P-dCTP-labeled subtracted rine IL-3 (10 ng/ml; Peprotech), recombinant human IL-6 (20 ng/ml;
PCR-Select populations. Hybridization and processing were per- kindly provided by Immunex), recombinant human G-CSF (10 ng/
formed according to protocols provided by the manufacturer. The ml; kindly provided by Kirin Pharmaceuticals, Tokyo, Japan), recom-
filters were analyzed on a phosphorimager and the relative hybrid- binant human EPO (5 U/ml; Ortho Pharmaceuticals), and recombi-
ization intensities were quantitated by Genome Systems. nant human Flt-3 ligand (75 ng/ml; kindly provided by Immunex).
Cells were plated in 35 mm dishes, incubated at 378C in 5% CO2/
95% air, and colonies were counted on day 9.Stem/Progenitor Cell Enrichment
Bone marrow cells were harvested by crushing femurs and tibia
CFU-S Assaywith a mortar and pestle in Hank's balanced salt solution containing
Bone marrow recipient animals (C57BL/6-Alpha-17) were exposed5% fetal calf serum (HBSS). Cell suspensions were subjected to
to 13 Gy of irradiation from a 137Cs source (Mark I gamma irradiator;repeated pipetting and filtered through nylon mesh (85 mm; Small
J. L. Shepherd and Associates) at a dose rate of 0.5 Gy/min. TheParts) to remove debris and connective tissue. Bone marrow cells
dose was delivered in two equal fractions separated by at least 3were magnetically lineage depleted and stained with phycoerythrin-
hr. Cells were transplanted into irradiated recipients by retroorbitalconjugated anti-Sca-1 (PharMingen) as previously described (Span-
injections under methoxyflurane anesthesia (Metofane, Mallinckrodtgrude et al., 1995). A FACS-Vantage instrument (Becton Dickinson
Veterinary). After lethal irradiation and subsequent transplantation,Immunocytometry Systems) was used for a Sca-1 enrichment sort
animals were maintained in a pathogen-free environment and neo-from the lineage-depleted bone marrow cell population, triggering
mycin sulfate (Biosol, Upjohn Company) was added to the drinkingon PE emissions in the enrich sort mode. Sorted cells were collected
water at a concentration of 2 mg/ml for the following 2 weeks.by centrifugation and stained again with phycoerythrin-conjugated
Spleens were harvested 13 days after transplantation, weighed, andanti-Sca-1 (PharMingen) and with allophycocyanin-conjugated anti-
fixed in Telleyesniczky's solution (70% ethanol-acetic acid-formalin,c-kit (CD117; PharMingen). Cells were sorted for the Sca-1posc-kitpos
20:1:1 by volume) before macroscopic surface colony count. Colonypopulation and collected by centrifugation. A small sample of the
weight was calculated after subtraction of the average weight ofsorted cells was used to perform a reanalysis (purity . 90%). Sorted,
spleens obtained from a parallel group of irradiated, untransplantedlineage-depleted and unsorted cells were stained with fluorescein-
animals.conjugated anti-CD27 (purified CD27 from PharMingen conjugated
to fluorescein using reagents obtained from Molecular Probes) and
analyzed for CD27 expression. For isolation of resting and activated Competitive Repopulation Assay
C57BL-Thy-1.1/Ly-5.1 double congenic mice (donor mice) andHSC, sorted cells were resuspended in prewarmed HBSS (378C;
10% FCS) containing 0.2 mM Rho (Molecular Probes). After 20 min C57BL/6J (B6; Thy-1.2/Ly-5.2) mice were bred and maintained in
the Animal Resource Center of the University of Utah. All mice wereof incubation, cells were collected again by centrifugation, resus-
pended in HBSS containing 10% fetal calf serum, and incubated at maintained on acidified water (pH 2.5) and autoclaved chow (Teklad
Immunity
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8640, Harlan Teklad) ad libitum. Bone marrow cells from donor mice Kondo, M., Weissman, I.L., and Akashi, K. (1997). Identification of
clonogenic common lymphoid progenitors in mouse bone marrow.were obtained and sorted for the CD27pos and CD27neg fraction of
the RholowSca-1posc-kitposLinneg cell population as described above. Cell 91, 661±672.
Ten cells of each group were sorted into a microtiter well containing Krause, D.S., Ito, T., Fackler, M.J., Smith, O.M., Collector, M.I.,
105 total bone marrow cells obtained from B6 mice. Cells were Sharkis, S.J., and May, W.S. (1994). Characterization of murine
transplanted as described above for CFU-S assays, and recipient CD34, a marker for hematopoietic progenitor and stem cells. Blood
animals were analyzed for hematopoietic reconstitution at various 84, 691±701.
time points. Peripheral blood samples were collected by retroorbital Lansdorp, P.M., Smith, C., Thornbury, G., Little, M.-T., and Dragow-
bleeding. Red blood cells were depleted and nucleated cells were ska, W. (1995). Reactivity of workshop mAb with CD341 bone mar-
immunofluorescently stained for syngeneic and congenic cells as row cells. In Leucocyte Typing V: White Cell Differentiation Antigens,
previously described (Spangrude et al., 1995). S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto,
C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.F. Tedder,
Acknowledgments and R.F. Todd, eds. (New York: Oxford University Press), pp. 1030±
1032.
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